Skip To Content
JEWISH. INDEPENDENT. NONPROFIT.
Make a Passover gift and support Jewish journalism. DONATE NOW
The Schmooze

WATCH: Timothée Chalamet And Steve Carell Film Looks Like ‘Notebook’-Level Tearjerker

“Titanic,” “The Notebook,” anything by “This Is Us” creator Dan Fogelman… now Timothée Chalamet and Steve Carell’s upcoming movie looks primed to top the list of movies that best clear our tear ducts.

“Beautiful Boy” will open October 12, and the new, full-length trailer for the movie is already blasting open the Oscar race. Based on a true story and memoir of the same name by father and son David and Nic Sheff, the wildly painful story charts Nic’s battle with addiction and its affect on his relationship with his father. Amy Ryan also stars in the movie, which is getting early rave reviews for both Chalamet and Carell’s acting.

We certainly won’t pass up on an opportunity to see Jewish “Call Me By Your Name” star Chalamet in a movie with the word “beautiful” in the title, or to see Steve Carell’s consistently outstanding dramatic acting. But the subject matter in “Beautiful Boy,” especially considering the ongoing opioid crisis, requires careful handling. We’re withholding judgement until we see what addiction survivors and experts say about the film. But, as a matter of public safety, we’re not withholding tissues (wouldn’t want to cause flooding.)

Behold, the trailer for “Beautiful (and heart-rending and touching and painful and devastating) Boy”:

Jenny Singer is the deputy lifestyle editor for the Forward. You can reach her at [email protected] or on Twitter @jeanvaljenny

This is a moment of great uncertainty. Here’s what you can do about it.

We hope you appreciated this article. Before you go, we’d like to ask you to please support the Forward’s independent Jewish news this Passover. All donations are being matched by the Forward Board - up to $100,000.

This is a moment of great uncertainty for the news media, for the Jewish people, and for our sacred democracy. It is a time of confusion and declining trust in public institutions. An era in which we need humans to report facts, conduct investigations that hold power to account, tell stories that matter and share honest discourse on all that divides us.

With no paywall or subscriptions, the Forward is entirely supported by readers like you. Every dollar you give this Passover is invested in the future of the Forward — and telling the American Jewish story fully and fairly.

The Forward doesn’t rely on funding from institutions like governments or your local Jewish federation. There are thousands of readers like you who give us $18 or $36 or $100 each month or year.

Support our mission to tell the Jewish story fully and fairly.

Republish This Story

Please read before republishing

We’re happy to make this story available to republish for free, unless it originated with JTA, Haaretz or another publication (as indicated on the article) and as long as you follow our guidelines.
You must comply with the following:

  • Credit the Forward
  • Retain our pixel
  • Preserve our canonical link in Google search
  • Add a noindex tag in Google search

See our full guidelines for more information, and this guide for detail about canonical URLs.

To republish, copy the HTML by clicking on the yellow button to the right; it includes our tracking pixel, all paragraph styles and hyperlinks, the author byline and credit to the Forward. It does not include images; to avoid copyright violations, you must add them manually, following our guidelines. Please email us at [email protected], subject line “republish,” with any questions or to let us know what stories you’re picking up.

We don't support Internet Explorer

Please use Chrome, Safari, Firefox, or Edge to view this site.